• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻链淀粉样变性中左心室收缩功能障碍的机制:一项多参数心脏磁共振成像研究

Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI study.

作者信息

Katznelson Ethan, Jerosch-Herold Michael, Cuddy Sarah A M, Clerc Olivier F, Benz Dominik C, Taylor Alexandra, Rao Shivani, Kijewski Marie Foley, Liao Ronglih, Landau Heather, Yee Andrew J, Ruberg Frederick L, Di Carli Marcelo F, Falk Rodney H, Kwong Raymond Y, Dorbala Sharmila

机构信息

Department of Cardiology, Weill Cornell Medical Center, New York, NY, United States.

CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Boston, MA, United States.

出版信息

Front Cardiovasc Med. 2024 May 30;11:1371810. doi: 10.3389/fcvm.2024.1371810. eCollection 2024.

DOI:10.3389/fcvm.2024.1371810
PMID:38873265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11169788/
Abstract

BACKGROUND

Cardiac systolic dysfunction is a poor prognostic marker in light-chain (AL) cardiomyopathy, a primary interstitial disorder; however, its pathogenesis is poorly understood.

PURPOSE

This study aims to analyze the effects of extracellular volume (ECV) expansion, a surrogate marker of amyloid burden on myocardial blood flow (MBF), myocardial work efficiency (MWE), and left ventricular (LV) systolic dysfunction in AL amyloidosis.

METHODS

Subjects with biopsy-proven AL amyloidosis were prospectively enrolled (April 2016-June 2021; Clinicaltrials.gov ID NCT02641145) and underwent cardiac magnetic resonance imaging (MRI) to quantify rest MBF by perfusion imaging, LV ejection fraction (LVEF) by cine MRI, and ECV by pre- and post-contrast T1 mapping. The MWE was estimated as external cardiac work from the stroke volume and mean arterial pressure normalized to the LV myocardial mass.

RESULTS

Rest MBF in 92 subjects (62 ± 8 years, 52 men) with AL amyloidosis averaged 0.87 ± 0.21 ml/min/g and correlated with MWE ( = 0.42;  < 0.001). Rest MBF was similarly low in subjects with sustained hematologic remission after successful AL amyloidosis therapy ( = 21), as in those with recently diagnosed AL amyloidosis. Both MBF and MWE decreased by ECV tertile ( < 0.01 for linear trends). The association of ECV with MWE comprised a direct effect (84% of the total effect;  < 0.001) on MWE from adverse interstitial remodeling assessed by ECV and an indirect effect (16% of the total effect;  < 0.001) mediated by MBF. There was a significant base-to-apex gradient of rest MBF in subjects with higher amyloid burden.

CONCLUSIONS

In AL amyloidosis, both MBF and MWE decrease as cardiac amyloid burden and ECV expansion increase. Both structural and vascular changes from ECV expansion and myocardial amyloid burden appear to contribute to lower MWE.

摘要

背景

心脏收缩功能障碍是轻链(AL)心肌病(一种原发性间质疾病)的不良预后标志物;然而,其发病机制尚不清楚。

目的

本研究旨在分析细胞外容积(ECV)扩大(淀粉样蛋白负荷的替代标志物)对AL淀粉样变性患者心肌血流(MBF)、心肌工作效率(MWE)和左心室(LV)收缩功能障碍的影响。

方法

前瞻性纳入经活检证实的AL淀粉样变性患者(2016年4月至2021年6月;Clinicaltrials.gov标识符NCT02641145),并接受心脏磁共振成像(MRI)检查,通过灌注成像量化静息MBF,通过电影MRI量化左心室射血分数(LVEF),通过对比剂前后T1映射量化ECV。MWE通过每搏量和平均动脉压计算得出的心脏外部功,并将其归一化为左心室心肌质量来估计。

结果

92例AL淀粉样变性患者(62±8岁,52例男性)的静息MBF平均为0.87±0.21ml/min/g,且与MWE相关(r=0.42;P<0.001)。成功治疗AL淀粉样变性后血液学持续缓解的患者(n=21)的静息MBF同样较低,与近期诊断的AL淀粉样变性患者相同。MBF和MWE均随ECV三分位数降低(线性趋势P<0.01)。ECV与MWE的关联包括通过ECV评估的不良间质重塑对MWE的直接影响(占总效应的84%;P<0.001)和由MBF介导的间接影响(占总效应的16%;P<0.001)。淀粉样蛋白负荷较高的患者静息MBF存在显著的心底到心尖梯度。

结论

在AL淀粉样变性中,随着心脏淀粉样蛋白负荷和ECV扩大增加,MBF和MWE均降低。ECV扩大和心肌淀粉样蛋白负荷引起的结构和血管变化似乎都导致MWE降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/2c4a290e8912/fcvm-11-1371810-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/08808d6faa84/fcvm-11-1371810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/6f9470c33bda/fcvm-11-1371810-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/6fc47988729a/fcvm-11-1371810-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/f00d4b727dae/fcvm-11-1371810-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/cdcb18aedd3f/fcvm-11-1371810-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/396547bc3d9a/fcvm-11-1371810-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/2c4a290e8912/fcvm-11-1371810-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/08808d6faa84/fcvm-11-1371810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/6f9470c33bda/fcvm-11-1371810-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/6fc47988729a/fcvm-11-1371810-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/f00d4b727dae/fcvm-11-1371810-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/cdcb18aedd3f/fcvm-11-1371810-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/396547bc3d9a/fcvm-11-1371810-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9772/11169788/2c4a290e8912/fcvm-11-1371810-g007.jpg

相似文献

1
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI study.轻链淀粉样变性中左心室收缩功能障碍的机制:一项多参数心脏磁共振成像研究
Front Cardiovasc Med. 2024 May 30;11:1371810. doi: 10.3389/fcvm.2024.1371810. eCollection 2024.
2
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging.系统性淀粉样变性心肌淀粉样沉积的测量:心血管磁共振成像的见解。
J Intern Med. 2015 May;277(5):605-14. doi: 10.1111/joim.12324. Epub 2014 Nov 24.
3
Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain Amyloidosis.系统性轻链淀粉样变的心肌特征、心脏结构和心功能。
JACC Cardiovasc Imaging. 2024 Nov;17(11):1271-1286. doi: 10.1016/j.jcmg.2024.05.004. Epub 2024 Jul 10.
4
Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.心脏磁共振成像组织图谱对心脏淀粉样变性预后的评估:一项系统综述和荟萃分析
Int J Cardiol. 2024 May 15;403:131892. doi: 10.1016/j.ijcard.2024.131892. Epub 2024 Feb 19.
5
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?系统性轻链淀粉样变中心脏淀粉样变负荷的改善定量:重新定义早期疾病?
JACC Cardiovasc Imaging. 2020 Jun;13(6):1325-1336. doi: 10.1016/j.jcmg.2020.02.025. Epub 2020 May 13.
6
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy.成功治疗后 1 年以上的轻链心脏淀粉样变性的心肌成分。
JACC Cardiovasc Imaging. 2022 Apr;15(4):594-603. doi: 10.1016/j.jcmg.2021.09.032. Epub 2021 Dec 15.
7
A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis.基于容积的心肌密度方法有助于解决心脏淀粉样变性中原发性 T1 与 ECV 悖论。
Sci Rep. 2022 Dec 16;12(1):21755. doi: 10.1038/s41598-022-26216-9.
8
Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.系统性轻链淀粉样变心肌细胞外容积分数的定量:平衡对比心血管磁共振研究。
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):34-9. doi: 10.1161/CIRCIMAGING.112.978627. Epub 2012 Nov 28.
9
Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.心脏轻链型淀粉样变的局部心肌微血管功能障碍:3T心血管磁共振评估
J Cardiovasc Magn Reson. 2016 Apr 6;18:16. doi: 10.1186/s12968-016-0240-7.
10
T1 mapping and survival in systemic light-chain amyloidosis.T1映射与系统性轻链淀粉样变性的生存情况
Eur Heart J. 2015 Jan 21;36(4):244-51. doi: 10.1093/eurheartj/ehu444. Epub 2014 Nov 16.

引用本文的文献

1
Myocardial Perfusion Imaging with Cardiovascular Magnetic Resonance in Nonischemic Cardiomyopathies: An In-Depth Review of Techniques and Clinical Applications.非缺血性心肌病的心血管磁共振心肌灌注成像:技术与临床应用的深入综述
Medicina (Kaunas). 2025 May 10;61(5):875. doi: 10.3390/medicina61050875.

本文引用的文献

1
Myocardial perfusion in cardiac amyloidosis.心脏淀粉样变的心肌灌注。
Eur J Heart Fail. 2024 Mar;26(3):598-609. doi: 10.1002/ejhf.3137. Epub 2024 Jan 21.
2
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.心脏磁共振成像在轻链淀粉样变中的应用指导治疗。
Eur Heart J. 2022 Dec 1;43(45):4722-4735. doi: 10.1093/eurheartj/ehac363.
3
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy.成功治疗后 1 年以上的轻链心脏淀粉样变性的心肌成分。
JACC Cardiovasc Imaging. 2022 Apr;15(4):594-603. doi: 10.1016/j.jcmg.2021.09.032. Epub 2021 Dec 15.
4
Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis.左心室心肌内膜活检中的淀粉样沉积物和纤维化与心脏淀粉样变性中的细胞外容积相关。
J Am Heart Assoc. 2021 Oct 19;10(20):e020358. doi: 10.1161/JAHA.120.020358. Epub 2021 Oct 8.
5
Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis.心脏轻链淀粉样变患者毛细血管密度的临床和预后意义。
ESC Heart Fail. 2021 Dec;8(6):5594-5599. doi: 10.1002/ehf2.13604. Epub 2021 Sep 16.
6
An Analysis of Myocardial Efficiency in Patients with Severe Asymptomatic Mitral Regurgitation.重度无症状二尖瓣反流患者心肌效率分析
J Cardiovasc Imaging. 2020 Oct;28(4):267-278. doi: 10.4250/jcvi.2020.0038.
7
Surrogates for myocardial power and power efficiency in patients with aortic valve disease.主动脉瓣疾病患者心肌作功和作功效率的替代指标。
Sci Rep. 2019 Nov 11;9(1):16407. doi: 10.1038/s41598-019-52909-9.
8
Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis.心肌耗氧量和心肌淀粉样变患者的效率。
J Am Heart Assoc. 2018 Nov 6;7(21):e009974. doi: 10.1161/JAHA.118.009974.
9
Diagnostic value of longitudinal flow gradient for the presence of haemodynamically significant coronary artery disease.纵向血流梯度对存在有血流动力学意义的冠状动脉疾病的诊断价值。
Eur Heart J Cardiovasc Imaging. 2019 Jan 1;20(1):21-30. doi: 10.1093/ehjci/jey129.
10
Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits.心肌纵向应变的相对尖端保留是由总淀粉样物质的区域差异解释的,而不是由淀粉样沉积物的比例解释的。
JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1165-1173. doi: 10.1016/j.jcmg.2018.06.016. Epub 2018 Aug 15.